Article
The dynamicity of mutant KRAS β2 strand modulates its downstream activation and predicts anticancer KRAS inhibition.
Life sciences - 1 Dec 2022
Pashapour Anousheh Jeiran, Barzegar Abolfazl, Hejazi Mohammad Saeid, Mehdizadeh Aghdam Elnaz
Abstract excerpt
AIM: Oncogenic mutations involving KRAS are human cancer's most common driving force. We aimed to determine specific conformational features of the active KRAS regarding downstream signaling activation, especially in mutant forms of KRAS. MAIN METHODS: We applied Molecular Dynamics (MD) simulations in triplicate and post-MD analytical methods on the KRAS and its G12 mutant structures. In addition, clustering,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
